Ledosin Soft Capsule (Clonixin Lysine Salt)

Adult dosage

Adults: Clonixin lysinate 125∼250 mg is administered orally 3 times daily.

This medication may cause gastric bleeding in individuals who regularly consume more than three drinks of alcohol daily; therefore, consultation with a physician or pharmacist is essential. This medication may increase the risk of cardiovascular disease, and serious problems such as myocardial infarction or stroke may occur; hence, individuals with a history of cardiovascular disease or risk factors should be particularly cautious. While taking this medication, serious gastrointestinal problems such as gastric bleeding, ulcers, or perforations may arise, especially in the elderly where the risk is higher, so it's crucial to immediately consult medical personnel if symptoms occur. Patients with peptic ulcers, those with drug allergies, persons who are hypersensitive to aspirin or other non-steroidal anti-inflammatory drugs, women who are pregnant or could become pregnant, and individuals with severe liver, kidney, or heart diseases should not take this medication. The risk of side effects may increase when taken concurrently with other non-steroidal anti-inflammatory drugs, ACE inhibitors, aspirin, diuretics, lithium, methotrexate, anticoagulants, immunosuppressants, antiplatelet agents, and corticosteroids, so they should either not be taken together or be observed carefully. Patients with a history of peptic ulcers or those with hypertension, fluid retention, heart failure, asthma, or liver or kidney disorders must consult medical personnel before taking this medication. It is advisable to discontinue breastfeeding or stop the medication during treatment, and if any adverse effects such as nausea, vomiting, abdominal pain, skin rash, anemia, abnormal liver function, drowsiness, or headache occur, the medication should be discontinued immediately and medical personnel consulted. This medication should be used at the minimum effective dose for the shortest duration, and regular blood tests along with liver and kidney function tests are necessary if taken long-term. This medication is symptomatic therapy that alleviates inflammation and pain but does not treat the underlying cause, hence treatment of the cause should also be considered. This medication can cause serious allergic reactions in some patients, so if a skin rash or itching occurs, the medication should be discontinued immediately. This medication may worsen hypertension and can cause fluid retention or edema, so patients with cardiovascular disease should take it with caution. This medication may affect the kidneys, so patients with impaired kidney function should be particularly careful, and if any abnormal symptoms arise, they must consult medical personnel immediately. Keep out of reach of children, and be careful not to transfer the medication to other containers.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, bleeding of the stomach or intestines, ulcer, perforation, nausea, vomiting, diarrhea, constipation, abdominal pain, peptic ulcer, shock, rash, itching, anemia, AST elevation, ALT elevation, drowsiness, headache, dizziness, cold sweats, chills, abnormal euphoria, jaundice, fulminant hepatitis, hepatic necrosis, liver failure, anemia, skin rash, exfoliative dermatitis, mucous membrane syndrome, toxic epidermal necrolysis, severe bronchospasm

This medication should be stored in a closed container to prevent exposure to air and moisture, ideally at a temperature between 1°C and 30°C at room temperature. This method of storage will safely maintain the drug's effectiveness.

Appearance

Blue, transparent oval soft capsule containing a light yellow transparent liquid

Package unit

10 capsules / PTP packaging